Public Company

Ranbaxy receives final USFDA approval for Glycopyrolate

Ranbaxy Laboratories today announced that it had received final approval from the US Food and Drug Administration (USFDA) to market and manufacture Glycopyrolate tablets. - India to export fresh litchi to US for first time - After mangoes, India to export litchis to US - Ranbaxy Labs launches protein supplement - Ranbaxy, Aurobindo get USFDA nod for migraine drug - Sun Pharma settles patent dispute with Astra Zeneca - Daiichi wins court battle against Mylan, Matrix The drug is indicated for use as adjunctive therapy in the treatment of peptic ulcer. The total annual market sales for Glycopyrolate was 426 million as of June 2009.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Unitech net profit falls 22% in Q4
Unitech Ltd, the country’s second-largest property developer, reported a decline of 22 per cent in its consolidated net profit for the quarter ended March 31 to Rs 279.7 crore, compared with Rs 360.2 crore for the corresponding period last year. Net profit for the full year 2008-09 also fell 28 per cent at Rs 1,197.7 crore, compared with Rs 1,661.9 crore for the corresponding period last year. Revenue for the year came down 23 per cent, to Rs 3315.6 crore, as compared with Rs 4,280.1 crore for the corresponding period last year.
Popular Articles
payday loan lenders

Posco gets final nod from Environment Min
South Korean steel giant Posco has finally got the clearance from the Environment Ministry for acquiring forest land for its proposed Rs 54,000-crore steel project in Orissa, which has been already delayed more than a year.

Sectoral package for exporters soon, says Sharma
The Commerce Ministry will announce sops for select exporters in the next few days, contrary to the Finance Ministry pitching for a roll-back of the stimulus packages to the industry.

© Copyright 2009